Angstrom Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Angstrom Pharmaceuticals, Inc. - overview
Established
1996
Location
Solana Beach, CA, US
Primary Industry
Pharmaceuticals
About
Angstrom Pharmaceuticals, Inc. is dedicated to providing innovative pricing solutions that enhance operational efficiency for businesses through timely pricing responses and a streamlined request process. Founded in 1996, Angstrom Pharmaceuticals, Inc. is located in Solana Beach, US.
The company focuses on delivering pricing request services to businesses and has engaged in 7 deals as of January 2009. The recent funding round raised USD 2. 00 mn from Pacific Gate Company Ltd. , totaling USD 2.
00 mn since inception. The firm was established by Himmat Singh, Janice H, and Yasser Ghassemi, with Arif Khan serving as the CEO. Angstrom Pharmaceuticals, Inc. specializes in providing solutions that streamline pricing processes for its clients.
The core offering includes a pricing request service that guarantees a response within 24 business hours, targeting small to medium-sized enterprises across various sectors in North America, primarily the United States and Canada. Angstrom Pharmaceuticals, Inc. generates revenue through its pricing request service, operating on a transactional basis. Clients submit inquiries and receive pricing within a specified timeframe, which supports B2B interactions.
The service structure involves one-off transactions, allowing clients to request pricing without long-term commitments, which aids them in negotiating purchases and managing budgets effectively. Looking ahead, Angstrom Pharmaceuticals, Inc. plans to develop new pricing solutions aimed at enhancing client offerings, though specific release dates are not disclosed. The company intends to expand its presence into additional geographic markets in North America by leveraging the recent funding secured in January 2009, which will support its growth initiatives and further strengthen its service capabilities.
Current Investors
Pacific Gate Company Ltd., Enhanced Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.angstrominc.com
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.